Brief: Elevation Oncology Reports First Quarter 2023 Financial Results And Highlights Recent Business Achievements
15/05/2023 12:54
Elevation Oncology Inc ELEV.O :
* ELEVATION ONCOLOGY REPORTS FIRST QUARTER 2023 FINANCIAL
RESULTS
AND HIGHLIGHTS RECENT BUSINESS ACHIEVEMENTS
* ELEVATION ONCOLOGY INC - NET LOSS FOR Q1 2023 WAS $17.1
MILLION,
COMPARED TO $17.3 MILLION FOR Q1 2022
* ELEVATION ONCOLOGY INC - RESTRUCTURING CHARGES WERE $5.1
MILLION
FOR Q1 2023
* ELEVATION ONCOLOGY INC - REMAIN ON TRACK TO INITIATE OUR
PHASE 1
TRIAL EVALUATING EO-3021 IN US IN SECOND HALF OF 2023
Source text for Eikon: ID:nPn8YLw5fa
Further company coverage: ELEV.O
Recent news on Elevation Oncology
See all newsBrief: Elevation Oncology Terminates License Agreement With CSPC Megalith Biopharmaceutical
U.S. RESEARCH ROUNDUP- Crane, Ryder System, Terex
Brief: Elevation Oncology Says Concentra To Buy Elevation Oncology For $0.36 Per Share Plus CVR
Elevation Oncology Inc expected to post a loss of 19 cents a share - Earnings Preview
Brief: Elevation Oncology Inc - To Prepay Term Loan Under Loan & Security Agreement Dated July 27, 2022 - SEC Filing